Previous Close | 5.49 |
Open | 5.57 |
Bid | 5.15 x 2200 |
Ask | 5.33 x 800 |
Day's Range | 5.14 - 5.60 |
52 Week Range | 2.92 - 7.50 |
Volume | |
Avg. Volume | 19,637 |
Market Cap | 31.913M |
Beta (5Y Monthly) | 1.15 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -4.85 |
Earnings Date | Nov 01, 2023 - Nov 06, 2023 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 22.58 |
Subscribe to Yahoo Finance Plus to view Fair Value for ECOR
ROCKAWAY, N.J., Sept. 21, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that Company CEO, Dan Goldberger, will present at iAccess Alpha’s – Top 10 Best Ideas from the Buyside Virtual Conference. Mr. Goldberger will also be available for one-on-one meetings held throughout the conference on September 26 and 27, 2023. iAccess Alpha’s – Top 10 Best Ideas from the Buyside Virtual Conference:Date: Tuesday, Se
ROCKAWAY, N.J., Sept. 07, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that Company CEO, Dan Goldberger, will present at the H.C. Wainwright 25th Annual Global Investment Conference. H.C. Wainwright 25th Annual Global Investment Conference:Date: Monday, September 11, 2023Time: Recorded presentation available starting at 7:00 am ETEvent: Company Presentation For more information regarding the conference
ROCKAWAY, N.J., Aug. 23, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic and wellness company, today announced that it has been completely vindicated in the securities class actions over the company’s 2018 initial public offering brought in the federal and state courts of New Jersey. The litigation has concluded without any finding of wrongdoing or liability, nor any payment, by electroCore. On July 13, 2023, District Judge Zahid N. Quraishi of the Uni